The diagnosis of LCNEC is established through neuroendocrine morphological features and immunohistochemical detection of at least one neuroendocrine marker CD56, synaptophysin, or chromogranin A in no less than 10% of tumor cells [4]. This evidence concerns the gene SYP and neoplasm.